Catalyst Wire Dossier Catalyst Wire Dossier

GX-G3

· Genexine, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX-G3, covering 2015-01-29 to 2015-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study GX-G3 in Healthy Subjects [Phase 1]

See pricing